Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma × Dietary Supplements × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Malnutrition 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Surgery--Complications 1 Peptic Ulcer 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Motor Activity 1 Malabsorption Syndromes 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced Head and Neck Carcinoma 1 Inflammatory Bowel Diseases 1 Infections 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Esophagitis 1 Duodenal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Cachexia 1

Interventions

Cyclophosphamide 24 Rituximab 16 fludarabine phosphate 13 Radiotherapy 12 Vincristine 10 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 Filgrastim 10 Cytarabine 10 Methotrexate 9 Exercise 9 Doxorubicin 9 Cyclosporine 9 Busulfan 8 Antilymphocyte Serum 8 Mycophenolic Acid 7 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 6 Surveys and Questionnaires 6 Prednisone 6 Prednisolone 6 Methods 6 Etoposide 6 Educational Status 6 Early Intervention, Educational 6 Blood Specimen Collection 6 Palliative Care 5 Leucovorin 5 fludarabine 4 Geriatric Assessment 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05982223 2023-08-08

Integrative Medicine in Lymphoma Survivors

Bnai Zion Medical Center

Phase NA Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡